a. Funding our working capital requirements; and b. General corporate purposes.
...
titutions under a business-to-government (B2G) framework. Our products are primarily generic formulations which are medicines for which the patents have expired and that are typically used as a substitute for other expensive branded medicines. We supply our products primarily under procurement contracts for central government projects under the Ministry of Health and Family Welfare through GoI agencies as well as state government agencies or bodies (together, “Government Customers”). Our products are supplied either under brand names or under their generic names, depending on the specific requirements and preferences of our customers. Regardless of the nomenclature, all our products (save for those we manufacture for others) carry our logo, ensuring consistent brand identity and quality assurance. We supplied our products across India to 27 States and Union Territories during the six months ended September 30, 2025, and to 27 states and Union Territories during Fiscal 2025. Read MoreMUFG Intime India Pvt Ltd.
Posted on Jan 20th
Rudra Ecovation informs about press release
Posted on Jan 20th
Nitin Nabin takes over as BJP president
Posted on Jan 20th
Currency futures for January expiry trade weaker with 7.31% increase in OI
Posted on Jan 19th
Shadowfax Technologies coming with IPO to raise Rs 2004.24 crore
The issue size of Hindustan Laboratories Ltd. IPO is ₹0.00 - 0.00 crore.
The Hindustan Laboratories Ltd. IPO opens for subscription on and closes on .
The price range of Hindustan Laboratories Ltd. IPO is ₹0.00 to ₹0.00.
The lot size of Hindustan Laboratories Ltd. IPO is shares.
The registrar of Hindustan Laboratories Ltd. IPO is MUFG Intime India Pvt Ltd..
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.